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EFFICACY OF A NEWLY FORMULATED FOAM ON GINGIVAL 
INFLAMMATION-A PILOT STUDY 
 
PRIYA GUPTA VAJRAPU 
 
ABSTRACT 
 
Periodontal disease, gingivitis and periodontitis are conditions that are a result of local 
response to supragingival dental plaque that forms due to poor personal oral hygiene. 
This is initiated by accumulation of bacterial biofilm on the teeth that leads to 
inflammatory changes in the gingival tissue. The pathogenesis of periodontitis has a 
multi-level architecture, composed of bacterial composition, environmental and genetic 
factors. Disruption of the oral biofilm by mechanical methods is one of the best 
alternatives for preventing periodontal disease. 
 
The present intervention study aimed at decreasing the gingival inflammation in 36 
patients with gingivitis or mild to moderate periodontitis by administration of a new 
dental product composed of antioxidants (dental foam). This study was conducted as a 
proof-of-concept study over 42 days and aimed to observe the earliest changes in gingival 
inflammation as measured by gingival index and bleeding on probing.  Clinical 
periodontal parameters including gingival index, bleeding on probing, plaque index and 
probing pocket depth were assessed at baseline, and 14, 28 and 42 days after baseline. 
Subjects in both treatment (n=24) and control (n=12) groups were given standard oral 
hygiene instructions including brushing with a standard toothbrush (Oral B® Pro health 
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medium) and standard toothpaste (GLO Science Toothpaste) twice a day.  Subjects in test 
group used the dental foam in addition to the standard toothpaste twice a day, while 
control group subjects did not use any additional product. 
 
The statistical analyses were performed to compare the mean changes from baseline to 
each post baseline time points using Student’s t-test. All statistical tests were conducted 
at p< 0.05 level of significance. There was a statistically significant reduction in the 
primary endpoints, gingival index (p=0.003) and bleeding on probing (p=0.007) in the 
test group when compared to the control group over 42 days. There were no statistically 
significant differences in the secondary outcomes, plaque index (p=0.07) and pocket 
depth (p= 0.12) between two groups.  Oral hygiene care including mechanical plaque 
removal with standard tooth brushing in combination with application of newly 
developed dental product (dental foam) has shown significant reduction in gingival 
inflammation when compared to standard tooth brushing alone and reveals beneficial 
effects in patients with gingivitis and mild to moderate periodontitis. 
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INTRODUCTION: 
 
The term gingivitis refers to inflammation of gingiva, and commonly occurs due to 
accumulation of biofilm containing bacteria on teeth. Gingivitis is a reversible type of 
periodontal disease, however if left untreated, gingivitis can progress to periodontitis, 
which is more advanced and can eventually lead to loss of teeth (Miller, 2012). 
Periodontitis is a prevalent disease with a pathological process, which leads to 
inflammation of the supporting tissues of the teeth including gingiva, periodontal ligament, 
alveolar bone and cementum (Figure 1). The progressive extension of gingival 
inflammation into the adjacent bone and periodontal ligament leads to destruction and 
eventually loss of periodontal ligament and alveolar bone (The American Academy of 
Periodontology , 2001).  
 Gingivitis is initiated by bacteria in the biofilm that causes pathological changes in 
the tissues directly or indirectly. The disease is limited to the gingival epithelium and 
connective tissue. Clinically, gingivitis is characterized by gingival redness, edema, 
bleeding, changes in contour, and increased in the volume of the gingival crevicular fluid 
(GCF) (Arul et al., 2014).  Periodontitis is clinically differentiated from gingivitis by the 
loss of connective tissue attachment and alveolar bone supporting teeth in the presence of 
progressive gingival inflammation. 
Both clinical and radiological evaluations are required to assess the severity and 
extent of the periodontal disease in the clinical setting. Clinically, probing pocket depth 
and clinical attachment level determines the extent and the severity of the disease. 
Radiographically, the amount of crestal (horizontal) and vertical bone loss in the 
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interproximal areas, width of the periodontal ligament space and bone loss in furcation 
areas depicts the severity of the disease. As the lesion progresses the bone loss also 
progresses apically (Anbiaee & Tafakhori, 2012). 
 
 
 
Figure 1 Anatomy of the Tooth. 
(Pandit, 2016) 
 
 Classification of periodontal disease: 
Several classifications have been used to categorize types of periodontal disease. 
Although many different classifications with different clinical manifestations of 
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periodontitis have been presented over 20 years, the 1989 American Academy of 
Periodontology (AAP) world workshop in clinical periodontics identified that periodontitis 
exists in several stages early onset, adult onset and necrotizing forms. Based on this AAP 
created the periodontal classification system  (Figure 2) (Armitage, 2004). 
 
 
Figure 2 Classification of Periodontitis.   
Shown are the five stages of periodontal disease (Armitage, 2004)  
 
In addition to the periodontal disease classification from the 1989 AAP world 
workshop, the European AAP workshop presented an alternate classification system in 
1999 (Armitage, 1999) . The European AAP found that there was not much supporting 
evidence to support the refractory stage of periodontitis. Moreover, the classification was 
not consistent enough to be applied to population in different countries and also it did not 
fit all models presented during the workshop. Hence the resulting classification was based 
on the scientific evidence and was presented by AAP international workshop in 1999 
(Figure 3).  
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Figure 3: Classification of Periodontitis  
Modifications to the 1989 AAP classification system (Armitage, 1999).     
 
 
Periodontitis is further sub-classified into the above mentioned categories based on 
the clinical, radiographic, historical, and laboratory characteristics. Chronic periodontitis 
is the most common form of periodontitis seen in adults but is also present in children as 
well. Chronic periodontitis is usually associated with the accumulation of plaque and 
calculus with, the disease progression rate varying from slow to moderate. The disease is 
described by the severity as slight, moderate or severe based on the amount of clinical 
attachment loss (Flemming, 1999). Slight periodontitis is defined as the amount of 
periodontal destruction ≤2 mm of clinical attachment loss (CAL), while sites with moderate 
periodontitis show 3-4 mm of CAL. Severe periodontitis is associated with >4 mm of CAL.  
Chronic periodontitis is sub classified into generalized and localized form based on the 
sites involved.  
Aggressive periodontitis differs from the chronic form by the rapid progression of 
the disease state, absence of accumulation of plaque and calculus, and familial history of 
5 
 
the aggressive disease (Novak & KF, 1996). This form of periodontitis is classified as early 
– onset periodontitis which was formerly sub-classified as pre pubertal, juvenile and 
rapidly progressive forms with localized or generalized disease distribution (Tonetti & 
Mombelli, 1999). Lately aggressive periodontitis is classified as localized and generalized. 
Periodontitis as a manifestation of systemic diseases is usually associated with the 
hematologic and genetic disorders of affected individual (Kinane, 1999). The majority of 
these disorders occur due to the alterations in the host defense mechanisms. The clinical 
manifestations of these disorders appear at an early age and may be mixed up with the 
aggressive form of periodontitis with rapid attachment loss and potential for early tooth 
loss.  Presently, periodontitis, as a manifestation of systemic diseases, is diagnosed when 
the systemic condition is the major predisposing factor and local factors such as large 
quantities of plaque and calculus are not clearly evident (Kinane, 1999). 
A causal relationship has been established between oral hygiene and gingivitis. The 
microbial flora in deep pockets of subgingival margin effects personal hygiene practices of 
individuals. Good oral hygiene can be achieved though removal of plaque by tooth 
brushing, flossing and professional cleaning, yet there are number of people who do not 
have sufficient dexterity to achieve the desired oral hygiene (Van Dyke et al., 1999). 
 
Epidemiology of Periodontal Disease: 
The National Institute of Dental and Craniofacial Research (NIDCR) reported that 
gingivitis is more severe and prevalent in adolescence when compared to early childhood 
and older age groups. Over 50% of adults had gingivitis on an average of 3 to 4 teeth and 
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subgingival calculus was present in 67% population (NICDR, 2014). According to a report 
by Center for Disease Control and Prevention (CDC), 47.2% adults aged 30 years and older 
have some form of periodontal disease (Eke et al., 2012). (Eke, et al., 2012). Disease 
progression increases with age and rises to 70.1% in adults 65 years and older. This 
condition is more common in men accounting for 56.4% than women who accounted for 
38.4% of periodontitis (CDC, 2013).  
Among people affected with severe periodontitis a significant majority (65.4%) 
was found in individuals living below the federal poverty level while those with less than 
a high school education constituted 66.9%, and current smokers accounted for  64.2% 
(CDC, 2015). It has been documented that only 5% to 15 % of any population suffers from 
severe generalized periodontitis even though the majority of the population is affected by 
the disease (Oliver et al., 1998).  
Many surveys have assessed the periodontal status in the U.S. population. The most 
popular of these surveys are the National Health and Nutrition Examination Survey 1971-
1974 that assessed the periodontal status visually. Later NHANES III 1998-1994 and 
NHANES 1999-2004 assessed the periodontal status using the partial mouth periodontal 
examination (PMPE). (Eke et al., 2012). Only two sites per tooth were assessed for pocket 
depth (PD) and clinical attachment loss during NHANES III and NHANES 1999-2000. 
This assessment further involved three sites per tooth using the PMPE at NHANES 2001-
2004. (Eke et al., 2010). After all these challenges and interpretations, it was suggested that 
in terms of pocket depth and attachment levels there has been an improvement in 
periodontal disease prevalence according to the NHANES survey data of 1998-2004 (Dye, 
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et al., 2007). Furthermore, full mouth periodontal examination (FMPE) began during 
NHANES 2009-2010, probing from six sites per tooth to establish true data on the 
prevalence of periodontitis in the United States. 
 
According to European Federation of Periodontology and other published studies 
(Eugenio et al., 2015), two or more interproximal sites with ≥ 6mm clinical attachment loss 
or one interproximal site with ≥ 5 mm CAL is defined as severe periodontitis. Whereas, 
two or more interproximal sites with CAL ≥ 4 mm or 5 mm pocket depth (PD) is classified 
as moderate periodontitis and two or more interproximal sites with ≥ 3 mm CAL or with ≥ 
4 mm PD is defined as mild periodontitis (James et al., 2001).  In NHANES 2009-2010, 
severity of PD and CAL were reported using measurements from all the six sites.  The 
mean and prevalence of CAL and PD ranged from 3 mm to 7 mm. the extent of disease 
was reported as 5, 10, and 30% of sites and teeth (Tonetti & Claffey, 2005). 
 
Etiology of Periodontal Disease: 
Gingivitis and periodontitis are inflammatory conditions of infectious nature 
(Williams, 1990). The disease has different stages ranging from mild gingivitis to 
irreversible and advanced conditions, including severe periodontitis (Jemin & Salomon, 
2006). Apart from pathogenic microorganisms, genetic and environmental factors also 
contribute to the development of periodontal disease. Earlier it was thought that periodontal 
disease occurred in response to plaque mass (non-specific plaque hypothesis), but later the 
specific microbial species were shown to be responsible of disease initiation and 
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progression (specific plaque hypothesis) (Loesche & Grossman, 2001). Formerly, the 
disease occurs in a site already colonized by a bacterial population such as the exogenous 
pathogens which include Capnocytophaga spp and Prevotella spp. More recently, 
additional studies have been conducted to support that there are unidentified and 
uncultivable microbial species that are essential for disease initiation and progression 
(Mario et al., 2008).  The rate of disease progression at the sites with baseline attachment 
loss is not always the same at all sites and time points (Goodson et al., 1982).  
One of the most significant developments in the etiology of periodontal disease is 
the role of dental plaque as a biofilm. Microbial plaque is the primary etiological factor in 
chronic inflammatory periodontal disease. The hard and soft tissues of the oral cavity such 
as masticatory mucosa, dorsum of the tongue, saliva, tooth surfaces and restorative 
materials are areas where bacteria colonize and create different ecosystems with different 
bacterial profiles. The bacteria adhere to these structures and form a matrix called “biofilm” 
that consists of mixed population of pathogens (Kolenbrander, 2000). The biofilm allows 
the microorganisms to unite and multiply on different surfaces (Rita, et al., 2011). It also 
protects the microorganisms from toxic substances in the environment and aids in the 
uptake of nutrients creating a suitable environment for their growth (Socransky & Haffajee, 
2002) .  
There are five major bacterial complexes classified by Socransky and Haffajee 
based on varying virulence. Some of the major gram negative anaerobes classified under 
red complex bacteria’s present at the diseased sites are Aggregatibacter (formerly known 
as Actinomyces) actinomycetemcomitans (Aa), Tannerella forsythensis (formerly known as 
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Bacteriodes forsythus), Porphyromonas gingivalis (Pg), Prevotella Intermedia (Pi), 
Fusobacterium nucleatum, Campylobacter rectus and Treponema denticola. (Socransky 
& Haffajee, 2002). The clones of these bacteria are closely associated with periodontitis 
and are found to be pathogenic. The supragingival plaque serves as a natural reservoir and 
bacteria in supragingival plaque migrates subgingivally to form a subgingival biofilm if 
supragingival plaque persists as conditions allow. 
Certain genetic factors are considered as risk factors for periodontal disease. For 
example, specific genotype polymorphic IL-1 gene cluster is one of the factors responsible 
for severe periodontitis. The pro inflammatory cytokine Interleukin (IL)-1 is a key 
regulator of the host response to a microbial infection especially in patients with history of 
smoking. Genotype IL-1 positive patients were found to have higher mean counts of 
individual virulent bacterial species in pockets deeper than 6mm, including Tanerella 
Forsythia (T. forsythia), Porphyromonas gingivalis (P. gingivalis) and Treponema 
denticola (T. denticola) (Samuel, et al., 2008). In addition, macrophages are in a hyper 
immune state, producing increased amounts of tumor necrosis factor- alpha (TNF- α), one 
of the major pro inflammatory cytokines that plays a role in gingivitis and leads to early 
and rapid bone loss in these individuals (Narayanan & Sonika, 2011). 
 
Environmental Factors:  
The association between periodontal disease, race and ethnicity is significantly 
attenuated when effects by confounders such as cigarette smoking and income are 
accounted for (Hyman & Reid, 2003). The increased risk of periodontitis in certain 
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racial/ethnic groups, such as African Americans, or Native Americans, may be partly 
attributed to socioeconomic, behavioral and other conditions. On the other hand, there is 
evidence that increased risk may also be partly related to biologic/genetic predisposition 
(Poulton, et al., 2002).  
The severity of periodontal disease can be attributed to factors such as poor oral 
hygiene, smoking and diabetes mellitus. Gingivitis and periodontitis are the inflammatory 
diseases of gingiva and supporting tissues, where the inflamed surface acts as the port of 
entry for various microbial pathogens (Peter, et al., 2009). The amount of bacterial 
pathogens present is varied between 108-1011 per mg of dental plaque, which may be 
sufficient to cause bacteremia when exposed to circulation and systemically spread 
bacterial products. These inflamed surfaces are caused by poor oral hygiene that leads to 
accumulation of plaque and calculus around the teeth. This in turn progressively leads to 
tooth loss by destructing the junctional epithelium and eventually leading to periodontal 
pocket formation. Similarly, there are many mechanisms through which the oral bacteria 
cause systemic diseases by direct or indirect effects (Xiaojing et al., 2000). 
Diabetes mellitus is such a systemic disease and is associated with an increased risk 
of tooth attachment loss. In these association studies, diabetic parameters examined 
included glycemic control, duration of disease, presence of other diabetes-associated 
complications and the population studied. Periodontal parameters include gingivitis, 
clinical attachment loss, and alveolar bone loss (Tomar & Asma, 2000). Studies have 
shown a relationship between poor glycemic control and periodontal disease suggesting 
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that poorly controlled diabetics respond less successfully to periodontal therapy compared 
to well-controlled and non-diabetics subjects (Van Dyke & Sheilesh, 2005).  
Apart from systemic diseases, periodontal disease serves as a risk factor for other 
inflammatory diseases such as cardiovascular disease, diabetes mellitus, preterm birth and 
pulmonary diseases. A study suggested that the rate of coronary heart disease increased by 
25% in subjects with periodontitis when compared to periodontitis free- individuals 
(DeStefano et al., 1993). Moreover, 70% of men with periodontitis younger than 50 years 
of age had an increased risk of coronary heart disease than men without periodontal disease. 
Adjusted odds ratio for preterm birth or low birth weight in women with severe periodontal 
disease was found as 7.5 in a study with 124 mothers. Attributable risk analysis indicated 
that as much as 18% of all preterm birth or low birth weight cases could be due to 
periodontal infections (Collins, et al., 1994). 
 
Pathogenesis of Periodontal Disease: 
The main goal in the treatment of periodontal disease is to eliminate the bacterial 
pathogens and contributing risk factors so that disease progression can be halted and the 
health of the periodontium can be preserved (Jemin & Salomon, 2006). The progressive 
gingival inflammation leads to loss of connective tissue attachment to the teeth which 
serves as a basis for clinically differentiating periodontitis from gingivitis (Listgarten, 
1986). Periodontitis leads to breakage in the lining of the periodontal ligament, disruption 
of its attachment to cementum as well as resorption of the alveolar bone. Apart from loss 
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of attachment there is migration of epithelial cells along the root surface causing resorption 
of alveolar bone (Jemin & Salomon, 2006).  
The inflammatory response in periodontal disease includes the activation of 
leukocytes, neutrophils, T-lymphocytes and plasma cells (Figure 4). They also release 
antibodies, lipopolysaccharides (LPS) and chemical inflammatory mediators. The 
lipopolysaccharides present in the gram-negative bacterial cell walls act as powerful 
stimulants for the complex host response.  Cytokines, chemokines and C-reactive protein 
are some of the chemical mediators released during the inflammatory process. Apart from 
these chemical mediators, other mediators such as TNF-a, interluekin-1 (IL-1) and 
prostaglandins ( e.g., prostaglandin E2-PGE2) stimulates fibroblasts and secretes matrix 
metalloproteinases (MMPs)  during the inflammatory process (Graves & Cochran, 2003). 
They are also responsible for the increased collagen breakdown and osteoclastic activity, 
which results in bone resorption increasing the destructive process.     
The level of periodontal destruction depends on the balance between destructive 
and protective inflammatory mediators. While periodontal bacteria are required for 
infective periodontal disease, individual response determines disease progression 
(Lovegrove, 2004). Clinical models of disease activity in periodontitis range from a 
continuous progression of disease, during which loss of attachment occurs at a slow rate 
over long periods of time to an episodic burst model in which loss of attachment occurs 
relatively rapidly during short periods of disease activity (Jeffcoat & Reddy, 1991). 
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Figure 4: Pathogenesis 
Shown are the destructive and protective factors that determine periodontal disease 
progression.  (Francis & Teresa, 2009) 
 
 
Clinical data indicate that the pathogenesis of periodontal attachment loss could differ 
between patients, periodontal sites and time points (Socransky et al., 1984) 
 
Clinical Assessment of Periodontal Disease:  
The periodontium is accepted to be normal when the pocket depth is no deeper than 
3 mm, whereas in a periodontal disease state the pocket depth is above 4 mm or greater 
(Michael et al, 1984). One of the most commonly used indices for assessment of the status 
of gingival health or inflammation is gingival index (G.I) developed by Löe and Silness 
(Stephen & Klaus, 1981). GI was the first index to evaluate all the tooth surfaces. All 
buccal, mesial, distal and lingual tooth surfaces of the gingival tissue are given a score of 
0-3 based on gingival redness, contour and edema. 
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Ramjford introduced the periodontal disease index (PDI) in 1967. He used partial 
recordings in his assessment of disease by examining a total of six teeth, which are now 
called the Ramjford teeth. He introduced the measure of CAL from the cementoenamel 
junction (CEJ), which serves as a fixed point. (Ramfjord, 1967).  CAL is apical migration 
of the junctional epithelium beyond the CEJ with loss of connective tissue attachment and 
alveolar bone. Due to examiner variation and lack of uniformity in CAL and PD values, a 
number of investigators have used their own criteria to define severe periodontitis. 
(Haffajee & Socransky, 1986)(Hugoson et al., 1992 ; Locker & Leake, 1993). To establish 
the definitions for periodontitis, the threshold values for CAL, PD, or both at a given site 
should be determined that provide evidence of periodontitis at that site. 
 
Treatment of Periodontal Disease 
Non-surgical therapy: 
 
The traditional approach in treating periodontal disease includes nonsurgical 
therapy followed by a surgical therapy. Phase 1 therapy is the first step that constitutes the 
periodontal treatment. This is a nonsurgical therapy with the main objective to eliminate 
pathogens and factors responsible for gingival and periodontal diseases (American 
Academy of Periodontology, 2000). The microbial pathogens and contributing factors can 
be eliminated by the treatment of the carious teeth, removal of calculus, corrections of 
defective restorations, and following a daily plaque control regimen (Axelsson & Lindhe, 
1974). In a phase 1 therapy the removal of plaque and calculus is controlled using 
mechanical aids including dental floss, scalers, curettes and ultrasonic instrumentation. 
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Defective restoration is re-contoured using finishing burs and diamond coated files used 
with hand piece, while the carious lesions are removed completely and treated with 
temporary or permanent restorations (Lee et al., 1971). Along with mechanical aids which 
play an important role in elimination of plaque, the use of appropriate antimicrobial agents 
and devices also serve to promote elimination of the microbial pathogens.  
 
Professional and Home Care with mechanical aids 
Oral measures alone seem to have limited effect on treatment of severe periodontal 
diseases. Therefore, mechanical aids are used that change the environment for the 
pathogens thereby reducing the host inflammatory response (Guthmiller & Karen, 2002). 
Periodontal treatment consists of debridement of the tooth and the root surfaces to reduce 
the bacterial pathogens that are inhabited. Maintenance of periodontal health following 
therapy includes life-long self-care and maintenance supplemented by professional care at 
varying intervals (3-6 months) (Elisabeth, 1996). Usually, oral hygiene practices consist of 
mechanical therapy, oral hygiene instructions and maintenance. 
Mechanical therapy includes the removal of supra and subgingival plaque and 
calculus by a professional procedure called scaling and root planning (Rajesh et al., 2011). 
Scaling and root planning is usually done using hand instruments or ultrasonic instruments 
followed by polishing using rubber cup and fluoride prophy paste. In maintenance therapy, 
disclosing agents are used to visualize plaque content on the teeth in order to administer 
the subject with various oral hygiene instructions. Oral hygiene instructions comprise of 
appropriate brushing technique, interdental devices including interdental brush and dental 
floss and fluoride applications during dental visits. These oral hygiene instructions are 
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given to achieve optimal plaque control by self-care. (Silvinha et al., 2010). Mechanical 
supragingival plaque control by self-care is the most important component in maintenance 
therapy (Rajesh et al.,  2011). 
The success of oral care by individuals depends on several factors. Often, dexterity 
is found as an important factor; however, brushing technique and type of tooth brush and 
tooth paste used are the most important factors and are not influenced by age and dexterity. 
On the other hand, use of mechanical aids such as interdental brushes and dental floss are 
used more frequently by younger age groups than older age groups due to dissemination 
of information that is more effective among young generations. (Demetriou et al., 1990). 
Some studies have shown that only 2-10% of the population use dental floss regularly and 
effectively. Moreover, the compliance of its use is reduced with time even with sufficient 
education and motivation (Enrico et al., 2011). Taking into consideration the problems with 
dexterity, complexity of the interdental aids and insufficient knowledge and education in 
the use of mechanical aids, mouthwashes with antimicrobial agents such with phenol, 
chlorhexidine, and essential oils were considered convenient and effective agents. The use 
of antimicrobial agents supplemented with mechanical aids is known to improve the oral 
health maintenance.  
 
Periodontal treatment with surgical therapy and systemic and local antibiotics: 
 The main purpose of the surgical therapy is to eliminate the pathological changes 
in the pocket wall and create a stable environment that could promote periodontal 
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regeneration. Another objective of the surgical phase is to correct the anatomic 
morphological defects that could potentially lead to accumulation of plaque and calculus. 
The mechanical periodontal treatment alone is adequate to resolve periodontitis, 
but adjunctive antimicrobial regimen, delivered systemically, can enhance the effect of 
therapy in certain cases. Antibiotics can be administered systematically or locally. When 
administered systematically the antibiotics penetrate the periodontal tissues via serum 
(Pejčić et al., 2010).  Even though the systemic delivery method has some disadvantages 
such as adverse drug reactions, patient compliance, antibiotic resistant micro-organisms 
their simple and easy mode of administration that enables to reduce the pathogens makes 
it more effective (Rohini et al., 2013).  Systemic antibiotics along with scaling and root 
planning (SRP) provide ancillary benefit in the treatment of periodontitis. Surgical therapy 
with proper oral hygiene can prevent progression of the disease and further periodontal 
attachment loss by providing an environment to reduce the accumulation of microbial 
pathogens. Antibiotics are used as an adjunct to control the periodontal disease activity.  
All the antibiotics used in periodontal therapy work to eliminate the major periodontal 
pathogens such as P. gingivalis, C. rectus and Capnocytophaga. Minocycline is the most 
effective antibiotic used in inhibition of the growth of periodontal pathogens (Anoop et al., 
2012). 
 
Results of the study by Griffiths et al. and Kaner et al. reported that administration 
of combinations of systemic antibiotics such as metronidazole and amoxicillin (MTZ+ 
AMX) and (SRP+MTZ+AMX) immediately or 3 months after the mechanical debridement 
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varies (Kaner, et al., 2007).  According to the study published by Griffiths, et al., systemic 
antibiotics administered during active phase of the periodontal therapy is more effective 
when compared to the administration of antibiotics during the healing phase (Griffiths, et 
al., 2011) . This is possibly due to the new stable biofilm community formed by the rapid 
and striking decrease of the microbial pathogens in recently scaled pockets. This stable 
biofilm niche is similar to the one seen in healthy individuals (Karin & Søren, 2016). 
 
In a local delivery method smaller doses of topical agents are delivered inside the 
pocket. The use of the local delivery method alone for administering antibiotics is an 
unconventional method of treatment for localized infections as this method does not 
provide superior results. Local delivery of antibiotics in combination with scaling and root 
planning (SRP) is most effective in sites that do not respond to conventional methods. 
Scaling and local delivery of antibiotics is a treatment approach in case of isolated areas 
with recurrent disease while, scaling with systemic antibiotics is an approach to treat 
generalized recurrence of the disease (Abinaya et al., 2012). 
There is limited information on the adverse events following antibiotic therapy in 
the literature. Most of the side effects reported are minor and are related to gastrointestinal 
problems. However, serious adverse events such as anaphylactic and allergic reactions 
were reported with the administration of penicillin and 10% of the side effects were 
considered fatal (Wilson et al., 2007). Microbial resistance following antibiotics therapy 
was reported in few studies (Feres, et al., 2002). Systemic antibiotics are useful 
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antimicrobial agents for the management of periodontal disease when used in combination 
with mechanical debridement for the disruption of the subgingival biofilm. 
 
Role of antioxidants in treatment of periodontitis: 
Periodontal disease increases the number of polymorphonuclear leukocytes 
(PMN)present and its activity. Localized PMNs cause oxidative damage to the gingival 
tissue, periodontal ligament and alveolar bone. The damage caused by the free radicals can 
be reduced by the antioxidant defense system (Gowri, Biju, & Suchetha, 2008). 
Though antibiotics can restrain the micro-organisms that contribute to periodontitis, 
they cannot directly act on the free radicals and oxidative stress that support inflammation. 
Cells require adequate amounts of antioxidants in order to prevent damage to the tissue by 
the free oxygen radicles (Pooja, 2016). Nitric oxide and oxidative stress play an important 
role in pathogenesis of periodontitis. Apart from these, hydrogen peroxide which is known 
to produce toxic gases in subgingival pocket, is considered linked to oxidative stress and 
periodontal disease. H2S producing cells in the oral cavity are available in the human 
periodontal ligament stem cells. Cystathionine synthase and lyase are the main source of 
endogenous hydrogen sulfide (H2S). H2S plays an important role in bacteria-induced 
inflammatory response due to its pro-inflammatory properties.  H2S is said to have both 
antioxidant properties by becoming cytoprotective and also to cause oxidative stress and is 
cytotoxic (Maria, et al., 2016). 
 The human body has natural antioxidants in saliva that can fight the free radicles 
by neutralizing them reducing inflammation. Antioxidants are available from various 
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sources including vitamins, minerals, hormones, enzymes and herbal supplements 
(Ravneet Kaur, et al., 2016). Several scientific articles revealed that many topical 
antioxidants are available which can supplement the natural antioxidants (Edward A. , 
2012) (Samuel B. , 2012).  Additionally, antioxidants have been found to reduce the 
severity of gingivitis, bleeding on probing and pocket depth.  Hence, topical application of 
antioxidants may provide additional benefits to people with periodontal disease by 
reducing inflammation and also this is the most convenient method used in the dental 
settings (Hans et al., 2012). 
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SPECIFIC AIMS: 
 
The present interventional study aims to assess the efficacy of a newly formulated 
dental foam in reducing gingival inflammation.  The hypothesis is that brushing with the 
new foam possessing antioxidant properties plus brushing with a standard toothpaste, is 
superior to brushing with a standard toothpaste alone in reducing gingival inflammation in 
gingivitis and/or periodontitis.  This project was primarily designed to test this hypothesis 
using the data sets of clinical periodontal measures including gingival index (GI), bleeding 
on probing (BOP), pocket depth, clinical attachment level and amount of plaque.  The 
primary endpoint measured was the change from baseline in gingival index and bleeding 
on probing at Day 42 in test and control groups. Secondary outcomes included change in 
plaque amount, and pocket depth from baseline to day 14, 28 and 42 compared to the 
control group and also gingival index, BOP from baseline to day 14 and day 28. This study 
was conducted in 36 subjects with gingivitis and/or moderate periodontitis and aimed at 
decreasing the gingival inflammation by administration of new dental foam over a period 
of 42 days to observe the earliest changes in gingival inflammation. 
 
 This study should help determine the efficacy of the newly formulated foam in 
reducing periodontal disease progression. 
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METHODS: 
 
The data sets used in this analysis are obtained from a randomized clinical pilot 
trial conducted at the Center for Clinical and Translational Research at the Forsyth 
Institute, Cambridge MA. The characteristics of the subject population included being 
medically healthy, 18-60 years of age, clinically diagnosed with gingivitis and/or 
periodontitis with a minimum of 20 natural teeth excluding third molars.  
General exclusion criteria included 1) chronic use of medications including non-
steroidal anti-inflammatory drug (NSAID’s), antidepressants, antibiotics, and beta 
blockers, 2) diabetes 3) participating in another trial or the use of other oral study products, 
4) pregnant or breast feeding women, 5) use of antibiotic within three months, 6) history 
of drug use that is associated with gum overgrowth (Dilantin, Nifedipine), 7) chronic use 
of anti-coagulants, immunosupressors, steroids, 8) medical condition which requires pre-
medication prior to dental visits/procedures, and 9) current smokers and former smokers 
within one year of enrollment. Dental exclusion criteria included 1) presence of orthodontic 
appliances, 2) soft or hard tissue tumor of oral cavity, 3) carious lesions that require 
immediate treatment, and 4) patients with severe chronic periodontitis, aggressive 
periodontitis, acute necrotizing ulcerative gingivitis or generalized gingival recession. 
The study protocol was approved by the Forsyth Institutional Review Board 
(FIRB). A total of 36 subjects were enrolled after a thorough screening process based on 
the inclusion/exclusion criteria followed by the informed consent process (Forsyth IRB 
#15-05). This study was a single blinded study, where the examiner was blinded to the 
group assignment. In randomized controlled trials, blinding is performed to reduce 
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intentional or unconscious bias by assessors and/or participants (Paul et al., 2010). Eligible 
subjects were scheduled for a baseline visit. The subjects were randomly assigned to 
treatment groups using a block size of six in a randomization schedule using a publically 
available website. The website is randomization.com 
(http://www.tufts.edu/~gdallal/randomcite.htm). Randomization.com uses the 
pseudorandom number generator of Wichmann and Hill (1982) as modified by McLeod 
(1985) (Suresh, 2011). Subjects were randomized using a 2:1 randomization scheme into 
either 1) brushing with test product + standard toothpaste or 2) brushing with standard 
toothpaste alone. The formulation of the test product used in this study is a propriety 
formulation. The main ingredients of the test product, antioxidants, are reportedly known 
to reduce gingival inflammation (Graziani, et al., 2015) . Also, this is a new approach with 
new formulations using antioxidants similar to toothpaste and is tested on existing 
gingivitis and periodontal inflammation. Subjects in the control group were instructed to 
brush their teeth with standard tooth paste alone twice a day for two minutes and those in 
the test group to brush with the test product together with the toothpaste twice a day for 2 
minutes.  Subjects were asked to return to the clinic at day 5, 14, 28 and 42 for safety and 
periodontal evaluations. Subjects were not permitted to use other dental hygiene products 
during the course of the study. 
Clinical periodontal measurements including pocket depth, gingival index, 
bleeding on probing and plaque index were recorded at baseline (Day 0) and repeated at 
each monitoring visit on Day 14, 28, and 42 following baseline. Safety evaluations 
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including adverse events and oral soft and hard tissue evaluation were recorded at baseline 
and repeated on Day 5, 14, 28, and 42. 
 
Periodontal clinical assessments:  
Gingival index (GI) (Löe and Silness, 1963) and plaque index (PI) (Silness and 
Löe, 1964) (Poulsen, 1981) were used to measure the degree and the extent of the gingival 
inflammation and the quantity of plaque. For the gingival index, the UNC -12 periodontal 
probe was placed slightly under the gingival margin and gently swept along the buccal and 
lingual surfaces to detect bleeding tendency and measure the severity of the inflammation. 
For the assessment of plaque, the probe is swept along the gingival margin on tooth surfaces 
(buccal and lingual surfaces) and the visible plaque is noted (Table 1).  
Probing depth, a measurement of the depth of the sulcus, was evaluated by 
measuring the distance from the gingival margin to the base of the sulcus with a UNC-12 
periodontal probe (Table 1, Figure 5). Six sites per tooth were measured and rounded down 
to the next whole mm (Figure 6). The clinical attachment level is the measurement of 
position of soft tissue with regard to the cemento-enamel junction (CEJ), which is a fixed 
point that does not change. The two measurements used to determine the clinical 
attachment level (CAL) are the probing depth and the distance from gingival margin to the 
CEJ  (Fritz, 2013)(Figure 5). Bleeding on probing was assessed after periodontal probing. 
This is a dichotomous scoring system which is used at six sites per tooth using one (1) and 
zero (0) for the presence or absence of bleeding 15 seconds after probing  
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Table 1 Scores for Bleeding on probing, Gingival Index and Plaque Index 
 
Standard criteria used to assess gingival health using scores from 0 to 3. Abbreviations 
BOP: bleeding on probing.  Table amended from Carranza’s Clinical Periodontology, 
1984. 
 
   
Scores Bleeding on 
Probing 
Gingival Index Plaque Index 
0 Absence of 
bleeding 
Normal gingiva No plaque 
1 Presence of 
bleeding 
Mild inflammation change in 
color, slight edema, No BOP 
Film at gingival margin 
2  
Presence of 
bleeding 
Moderate inflammation: 
redness, edema, BOP 
Moderate (easily 
visible) 
3  
Presence of 
bleeding 
Severe inflammation : marked 
redness & edema, ulceration 
and spontaneous bleeding 
Abundance of material 
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Figure 5 Probing depth ;  
Entire sulcus is probed using UNC-12 and the distance between the Cemento-enamel 
junction and gingival margin is recorded and is rounded to nearest mm  (Preshaw, et al., 
2012) 
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Figure 6 Anatomy of a molar 
Shown are the six sites per tooth that are assessed, 3 buccal and 3 lingual sites (Edward, 
2007) 
 
 
 
Statistical Analysis: 
All statistical analysis was conducted using Microsoft excel. In an Intent-to-Treat 
(ITT) analysis, the data collected on all randomized subjects at any post-baseline visit was 
included in the data analysis despite any missing visits. The data was presented as mean ± 
standard deviation (SD). The main objective of the study was to assess the change in 
gingival index and BOP from baseline to day 42 compared to the control group. This 
clinical data is measured by taking an average mean of all the indices for each subject and 
then the change from baseline to each point is calculated for each person. These changes 
would then be compared between the test group and the control group. Secondary measures 
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included the change in gingival index, BOP, plaque amount, and pocket depth from 
baseline to day 14, 28, and 42 compared to the control group. 
The treatment changes from baseline to each time point were evaluated using the 
paired t-test. A level of p < 0.05 was considered statistically significant. Differences 
between baseline and day 14, 28 and 42 between test and control groups were compared 
using unpaired t-test. The categorical variables between groups including gender and race 
were analyzed using a chi-square test. 
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RESULTS 
 
The clinical data from a total of 36 subjects (19 females (53%) and 17 males (47%)) 
participating in the study were included in this analysis testing the efficacy of a newly 
formulated dental product in reducing gingival inflammation compared to a control group.  
Table 2 represents the demographic characteristics and Table 3 represents the 
clinical characteristics of both study groups. Descriptive statistics and the mean values of 
the clinical parameters are shown in Table 5.  The study sample constituted of 53% females 
and 47% males, and were primarily (45%) white. The second largest racial category were 
black who constituted 40% of the study sample and the remaining subjects  were comprised 
of Asians, Hispanic and mixed race representing the racial distribution of Greater Boston 
and Cambridge areas. The mean age of the study sample was 42 years (+/-11.44 SD) (Table 
2). 
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Table 2 Demographic characteristics of study participants by group 
Descriptive statistics for demographics in both groups 
 
Characteristics Test group 
 n=24 
Control group 
n=12 
p-value 
Age (mean ± SD)  
 
41.17 ± 11.44 39.08 ± 12.61   0.64 
Gender, n (%) 
Male 
Female 
 
 
10 (41.6%) 
14 (58.3%) 
 
7 (58.3%) 
5 (41.6) 
    
  0.35 
Race, n (%) 
Mixed 
Asian 
White 
Black 
Hispanic 
 
2 (8.3%) 
3 (12.5%) 
12 (50%) 
5 (20.8%) 
2 (8.3%) 
 
1 (8.3%) 
0 (0%) 
4 (33.3%) 
7 (58.3%) 
0 (0%) 
 
 
0.17 
 
 
Table 3 Baseline clinical parameters of study participants   
 
Gingival index, bleeding on probing, plaque index and pocket depth were measured in 
control subjects as well as test subjects treated with the newly formulated product.  Data 
presented as Mean± standard deviation (s.d.). 
 
Clinical 
parameters  
Test group  
n=24 
Control group  
n=12 
Gingival Index  1.86 ± 0.19 1.84 ±0.12 
Bleeding on 
Probing (%) 
 
35% 35% 
Plaque Index  1.30 ± 0.34 1.15 ±0.46 
Pocket Depth 2.19 ± 0.30 2.33 ±0.33 
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Table 4 Change in Gingival Index and Bleeding on Probing from baseline to day 42: 
 
Element of primary outcome - comparison of gingival index (GI) and bleeding on 
probing (BOP) change in control and test groups from baseline to day 42. Data presented 
as mean ± standard deviation. 
 
 
 
 
According to table 4 and table 5, we can see that there is a very minimal change between 
the test and the control group at baseline, which dramatically changed at day 42. 
  
Group 
Baseline 
GI 
Day 42 
Gingival GI 
Baseline 
BOP 
Day 42 
BOP 
Change= 
Day 42- baseline 
Test  1.86 ± 0.19 1.63 ± 0.19 35% 26% GI= -0.23  
BOP = -8%  
Control 1.84 ±0.12 1.83 ± 0.16 35% 36% GI= -0.01 
BOP = 1%  
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Figure 7 Change in Gingival Index from baseline to Day 42.  Shown is the change in 
gingival index (GI) between control and test subjects following use of the newly 
formulated product.  Data collected a baseline and at day 42. 
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Figure 8 Change in Bleeding on Probing from baseline to day 42 
Shown is the change in bleeding on probing (BOP) between control and test subjects 
following use of the newly formulated product.  Data collected at baseline and at day 42.   
 
The change in baseline to day 42 for GI and BOP are the primary outcome measures.  There 
was a statistically significant reduction in gingival index and bleeding on probing from 
baseline to day 42 in the test group compared to control group (p<0.003 and p<0.007, 
respectively) (Table 5) and Figure 7, Figure 8.   
 
 
 
 
 
 
 
Table 5.  Differences in Mean Gingival Index, Bleeding on Probing, Plaque Index and 
Probing Depth at baseline, Day 14, Day 28 and Day 42 between groups 
0
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34 
 
 
Shown is the change in gingival index (GI) between control and test subjects following 
use of the newly formulated product.  Time points collected include baseline and day 14, 
28 and 42.  Data presented as mean ± standard deviation. Statistically significant 
difference compared to control group (p<0.05) shown by asterisk*. 
 
 
Endpoint 
Time point Test group (n=24) Control group  
(n=12) 
p-value 
Gingival 
Index 
Baseline 1.86 ± 0.19 1.84 ±0.12 0.62 
Day 14 1.71 ± 0.2 1.76 ± 0.16 0.44 
Day 28 1.67 ± 0.19 1.79 ± 0.14 0.05* 
Day 42 1.63 ± 0.2 1.83 ± 0.16 0.003* 
 
Bleeding 
on 
Probing 
Baseline 35% 35% 0.91 
Day 14 28% 31% 0.39 
Day 28 28% 35% 0.05* 
Day 42 26% 36% 0.007* 
 
Plaque 
Scores 
baseline 1.30 ± 0.34 1.15 ± 0.46 0.35 
Day 14 1.06 ± 0.35 1.23 ± 0.43 0.24 
Day 28  1.05 ± 0.37 1.21 ± 0.51 0.35 
Day 42 0.93 ± 0.36 1.18 ± 0.38 0.07 
 
Probing 
Depth 
baseline 2.19 ± 0.3 2.33 ± 0.33 0.22 
Day 14 2.13 ± 0.3 2.31 ± 0.34 0.14 
Day 28  2.14 ± 0.31 2.30 ± 0.32 0.18 
Day 42 2.13 ± 0.31 2.33 ±0.37 0.12 
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A statistically significant difference was found between GI (p <0.003) and BOP 
(p<0.007) in the test group from baseline to day 42 when compared with the control group. 
Apart from being statistically significant, these results are clinically meaningful. The 
changes that are seen in the intervention group are clinically important. The mean values 
for probing depth and plaque index also showed a reduction from baseline to day 42 in test 
group, however, when compared to control group, the differences were not statistically 
significant (p<0.12 and p < 0.07, respectively) (Table 6).  
 
 
 
Figure 9 Change in Gingival Index from baseline to day14, day 28 and day 42  
Shown is the change in Gingival Index(GI) between control and test subjects following 
use of the newly formulated product.  Data collected at baseline and at day 14, 28, 42.   
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Figure 10 Change in Bleeding on Probing (BOP) from baseline to day 14, day 28, day 42 
Shown is the change in Bleeding on Probing (BOP) between control and test subjects 
following use of the newly formulated product.  Data collected at baseline and at day 14, 
28, 42.   
  
 
 
Secondary outcome measures include the reduction in plaque index, and pocket 
depth from baseline to day 14, 28 and 42 and change in gingival index and BOP from 
baseline to days 14 and 28. Change in plaque scores decreased from baseline (0.24) to day 
42 in test group (0.12), while in control group the plaque scores increased at day 14 and 
decreased at day 42 (Table 7) (Figure 11). Changes in pocket depth were not found to be 
statistically different. The probing pocket depth showed incremental but steady change 
over time in the test group. Figure 12 and Table 7. 
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Figure 11 Change in Plaque Index (PI) from baseline to day 14, day 28 and day 42 
Shown is the change in Plaque Index (PI)between control and test subjects following use 
of the newly formulated product.  Data collected at baseline and at day 14, 28, 42.   
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Figure 12 Change in Pocket Depth  (PD) from baseline to day 14, day 28 and day 42 
Shown is the change in Pocket Depth (PD)between control and test subjects following 
use of the newly formulated product.  Data collected at baseline and at day 14, 28, 42.   
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Table 6 Change in Clinical parameters from Baseline to Day 42 
 
Comparison of mean change between the intervention and control group at each time 
point starting at baseline to day 14, day 28 and to day 42. Decrease in change between 
time points, Increase in change between time points.  
 
 
 
Change in the clinical 
parameters from 
baseline to day 42 
Intervention group 
(n=24) 
Control group  
(n=12) 
Gingival 
Index 
Baseline to Day 14 0.15    0.08     
Day 14 to Day 28 0.04    -0.03   
Day 28 to Day 42 0.04    -0.04   
 
Bleeding 
on 
Probing 
Baseline to Day 14 7%        (No change) 
Day 14 to Day 28 (No change) 4%      
Day 28 to Day 42 2%       1%      
 
Plaque 
Scores 
Baseline to Day 14 0.24    -0.08   
Day 14 to Day 28 0.01    0.02     
Day 28 to Day 42 0.12    0.03     
 
Probing 
Depth 
Baseline to Day 14 0.06    0.02     
Day 14 to Day 28 -0.01   0.01      
Day 28 to Day 42 0.01     -0.03    
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Changes within the group have been evaluated using the paired t-test. The change 
within the group between each time point is calculated and is compared with the other 
group (Table 7). There was a significant reduction in gingival index from baseline (0.15) 
to day 42 (0.04) in the test group. Conversely, in the control group, the mean gingival index 
increased from baseline (0.08) to day 42 (-0.04). Likewise, bleeding on probing 
dramatically reduced at day 42 compared to baseline (35% to 26%) in the test group. The 
changes in control group, however, were smaller and were not significantly different (Table 
7 and Figure 10). The descriptive analysis and statistical tests compared the data between 
groups revealed that the mean values of gingival inflammation and bleeding on probing 
significantly reduced in the test group when compared to the control group at both day 28 
and 42).  
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DISCUSSION 
 
In this randomized clinical study, we analyzed the efficacy of a new dental product 
on the reduction of gingival inflammation as measured by the periodontal clinical indices 
GI, BOP, PI, and PD. Subjects were assigned to either the test group brushing with the new 
product along with a standard toothpaste or to the control group brushing with a standard 
toothpaste only. Data collected demonstrated that the newly formulated dental product, 
when used in conjunction with a commercially available toothpaste, resulted in significant 
reduction in gingival inflammation over a 42-day period in subjects with gingivitis or 
periodontitis. The control group receiving toothpaste alone showed increased level of 
gingival inflammation over the same period. The study results indicate that the newly 
formulated dental product is effective in controlling gingival inflammation and maintaining 
gingival health in subjects susceptible to gingival inflammation and gingival diseases.  
There was a significant reduction in GI and BOP values in the test group receiving 
the new foam. This could be attributed to the antioxidant properties of the product. The 
gingival bleeding is an important indicator of risk for periodontitis (Lucarini, et al., 2008) 
. Gingival bleeding helps in assessing the clinical attachment level changes and hence 
serves as a surrogate measure in the prevention of periodontitis. There was a steady 
decrease in mean bleeding on probing percentage from 35% at the baseline to 26% at day 
42 which further indicates the control of inflammation and oral health status.  
With respect to the findings from the review by Needleman et.al, there is greater 
reduction in gingival bleeding and plaque when treated with professional mechanical 
plaque removal and oral hygiene instructions (OHI) when compared to no treatment 
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(Needleman et al., 2015). Also, there is some evidence from these studies that the plaque, 
bleeding and attachment loss benefit more from frequent mechanical plaque removal. The 
decrease of plaque index in the current study is not statistically different but there was a 
noticeable amount of reduction in plaque score in test group (1.30-0.93 points) assigned to 
new product when compared to the control group (1.15- 1.18 points). Some studies have 
shown a significant reduction in pocket depth in both deeper and shallow sites following a 
skilled tooth brushing technique with follow up (Takashi et al., 2004). Conversely, in our 
study even though the reduction in pocket depth was not statistically significant, there was 
a reduction in pocket depth in test group (2.19-2.13 points), when compared to the control 
group (2.33-no change). 
There was a significant reduction in bleeding on probing (p<0.007) in the test group 
that used the new foam together with toothpaste when compared to the control group that 
used the toothpaste alone. This is in accordance to the study by Gonzalez et al. in which 
bleeding on probing decreases substantially after professional mechanical removal of 
plaque but there was not much improvement after conventional oral hygiene alone 
(Gonzalez, et al., 2014). 
A report by European Workshop of Periodontology supported the universal 
recommendations to brush twice daily for two minutes (Chapple, et al., 2015).  Whereas, 
in a meta-analysis that reviewed much of clinical trials between 2002 and 2005 found that 
mechanical removal of plaque using tooth brush combined with removal of interdental 
plaque once in 24 hours is adequate to prevent the onset of gingival inflammation (Akshay 
& Vandana, 2012). In this context our results provide clinical evidence to maintain gingival 
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health with the use of a newly formulated dental foam along with standard tooth brushing 
twice daily for two minutes.  Strengths of the study include the study design and assessment 
of compliance. Randomization helps in providing the comparable groups at baseline and 
removes any confounding variables. Blinding reduces the measurement bias that could be 
caused by the examiner. Study limitations include stringent inclusion criteria which 
question the validity of the study in large subject populations due to the difficulty in 
generalizing the results, as the studied population is different from the population in normal 
life. Thus, the results of this foam might differ in the population outside the study. Another 
limitation of the study would be that subjects were restricted from using other dental aids 
which in reality is difficult to apply. One future studies could be a longitudinal clinical trial 
including large and diverse population with severe periodontal disease. 
CONCLUSIONS 
In this study, reduced scores of gingival index (GI) and bleeding on probing (BOP) were 
observed in the test group using newly developed foam along with standard toothbrush and 
paste compared to a control group using tooth brush and paste alone. These results suggest 
that the new dental product with antioxidant properties present efficacious changes in 
gingival inflammation which could be beneficial to the daily oral hygiene of subjects 
susceptible to gingivitis and periodontitis. 
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